american academy of cardiology glp-1 GLP-1s Should Be First Step to Prevent Heart Disease, ACC Says 367. GLP-1 Agonists: Clinical Implementation

There hasnt been a medical innovation thats been this impactful, really, since the advent of statins, Nunn said in a phone interview, referring to the cholesterol-lowering drugs that premiered in 1987 and were prescribed to an estimated 92 million Americans in 2018 and 2019

This fast climb owes to broader societal focus on weight management and payer realization that sustained weight loss lowers downstream cardiovascular costs

The patent landscape also discourages smaller manufacturers from entering the space

Its not always easy to identify when you might have a thyroid problem because the symptoms, such as fatigue and feeling cold, can be so nebulous